| Recruiting | Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance Mycosis Fungoides, Sezary Syndrome | — | 2025-05-02 |
| Recruiting | Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension Healthy Volunteers Essential Hypertension | Phase 1 | 2025-04-03 |
| Recruiting | Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） Achondroplasia | Phase 3 | 2024-12-01 |
| Recruiting | Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia Relapsed or Refractory Acute Myeloid Leukemia | Phase 1 | 2024-10-10 |
| Recruiting | A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia X-linked Hypophosphatemia | Phase 1 / Phase 2 | 2024-10-09 |
| Active Not Recruiting | Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration Neovascular Age-Related Macular Degeneration (nAMD) | Phase 2 | 2024-01-31 |
| Recruiting | A Study of KK2269 in Adult Participants With Solid Tumors Advanced Solid Tumor, Metastatic Solid Tumor, Gastric Adenocarcinoma | Phase 1 | 2024-01-18 |
| Active Not Recruiting | Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema Diabetic Macular Edema (DME) | Phase 2 | 2024-01-09 |
| Recruiting | A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors | Phase 1 | 2023-11-01 |
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO Tumor-Induced Osteomalacia (TIO) | Phase 4 | 2022-09-07 |
| Active Not Recruiting | A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Ery Healthy Volunteers, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) | Phase 1 | 2022-08-03 |
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH X-linked Hypophosphatemia (XLH) | Phase 4 | 2021-11-01 |
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH X-linked Hypophosphatemia (XLH) | Phase 4 | 2021-09-28 |
| Completed | A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma Multiple Myeloma and Malignant Lymphoma | Phase 2 | 2021-09-01 |
| Active Not Recruiting | Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreat Aplastic Anemia | — | 2021-05-10 |
| Completed | Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia | Phase 3 | 2021-03-15 |
| Completed | Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia | Phase 3 | 2021-03-15 |
| Completed | Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia | Phase 3 | 2021-03-08 |
| Completed | Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis Hyperphosphatemia | Phase 3 | 2021-03-03 |
| Withdrawn | A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 4 | 2021-01-01 |
| Active Not Recruiting | Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Indolent B-cell Non-Hodgkin's Lymphoma | Phase 2 | 2020-09-17 |
| Terminated | A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration Healthy Volunteers, Wet Age-related Macular Degeneration | Phase 1 | 2020-09-16 |
| Completed | A Through QT/QTc Study of KW-6356 Parkinson's Disease | Phase 1 | 2020-03-31 |
| Completed | Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers Healthy Volunteer | Phase 1 | 2019-12-20 |
| Completed | Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia Aplastic Anemia | Phase 2 / Phase 3 | 2019-12-03 |
| Completed | KW-3357 Study in Patients With Early Onset Severe Preeclampsia Preeclampsia | Phase 3 | 2019-11-19 |
| Completed | A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin Parkinson's Disease | Phase 1 | 2019-08-27 |
| Completed | A Study of RTA 402 in Obese Adults Obese Adult Male | Phase 1 | 2019-08-20 |
| Completed | A Study of KHK4827 in Subjects With Palmoplantar Pustulosis Palmoplantar Pustulosis | Phase 3 | 2019-08-10 |
| Completed | KRN125 for Mobilization of Hematopoietic Stem Cells Peripheral Blood Stem Cell Transplantation | Phase 2 | 2019-05-28 |
| Completed | A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis Moderate to Severe Systemic Sclerosis | Phase 3 | 2019-05-23 |
| Completed | A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin Parkinson's Disease | Phase 1 | 2019-05-22 |
| Completed | Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2019-04-29 |
| Completed | Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients Hyperphosphatemia | Phase 2 | 2019-04-29 |
| Completed | Study of AMG531(Romiplostim) in Patients With Aplastic Anemia Aplastic Anemia | Phase 2 / Phase 3 | 2019-04-25 |
| Completed | Dose-finding Study of KHK7791 in Hyperphosphatemia Patients Hyperphosphatemia | Phase 2 | 2019-04-15 |
| Completed | Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia Secondary Hyperparathyroidism | Phase 3 | 2019-04-09 |
| Completed | A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults Healthy Subject | Phase 1 | 2019-04-04 |
| Completed | A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects Parkinson's Disease | Phase 1 | 2019-02-26 |
| Terminated | Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2019-02-22 |
| Completed | A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD Hyperphosphatemia | Phase 2 | 2018-12-27 |
| Completed | A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Parkinson's Disease | Phase 2 | 2018-09-29 |
| Terminated | A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study Diabetic Kidney Disease | Phase 3 | 2018-05-30 |
| Active Not Recruiting | Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collabora X-Linked Hypophosphatemia | — | 2018-05-01 |
| Completed | A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia XLH | Phase 3 | 2018-01-09 |
| Completed | A Study of KHK4827 in Patients With Systemic Sclerosis Systemic Sclerosis | Phase 1 | 2017-10-06 |
| Completed | Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer Advanced or Recurrent Breast Cancer | Phase 2 | 2017-09-22 |
| Completed | Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Parathyroid Carcinoma, Primary Hyperparathyroidism | Phase 3 | 2017-08-30 |
| Completed | A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia X-linked Hypophosphatemic Rickets/Osteomalacia | Phase 3 | 2017-07-06 |
| Terminated | A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM) HTLV-1 Associated Myelopathy | Phase 3 | 2017-05-22 |
| Completed | A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis Dermatitis, Atopic | Phase 1 | 2017-04-10 |
| Completed | A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA) Axial Spondyloarthritis | Phase 3 | 2017-03-07 |
| Completed | A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease Alzheimer Disease | Phase 1 | 2017-03-03 |
| Completed | A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis Healthy Men and Subjects With Ulcerative Colitis | Phase 1 | 2016-12-01 |
| Completed | A Study of KW-6356 in Subjects With Early Parkinson's Disease Parkinson's Disease | Phase 2 | 2016-09-01 |
| Completed | A Phase 4 Clinical Study of Brodalumab Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris | Phase 4 | 2016-07-04 |
| Completed | Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis Eosinophilic Chronic Rhinosinusitis | Phase 2 | 2016-06-01 |
| Completed | Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Aplastic Anemia | Phase 2 / Phase 3 | 2016-05-01 |
| Completed | A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome | Phase 2 | 2016-04-01 |
| Completed | A Study to Evaluate Abuse Potential of Istradefylline Drug Abuse | Phase 1 | 2016-01-01 |
| Completed | Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease Idiopathic Parkinson's Disease | Phase 3 | 2015-12-01 |
| Completed | Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer Breast Cancer | Phase 1 | 2015-11-01 |
| Completed | Phase 3 Study of KHK7580 Secondary Hyperparathyroidism | Phase 3 | 2015-09-29 |
| Completed | Phase 3 Study of KHK7580 Secondary Hyperparathyroidism | Phase 3 | 2015-09-28 |
| Completed | Phase 3 Study of KHK7580 Secondary Hyperparathyroidism | Phase 2 / Phase 3 | 2015-09-01 |
| Completed | Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Solid Tumor | Phase 1 | 2015-06-01 |
| Completed | A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. Alzheimer's Disease | Phase 1 | 2015-03-01 |
| Completed | The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | 2014-12-01 |
| Completed | Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline Hepatic Impairment | Phase 1 | 2014-08-01 |
| Completed | Phase 2 Study of KHK7580 Secondary Hyperparathyroidism | Phase 2 | 2014-07-01 |
| Completed | A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia X-linked Hypophosphatemic Rickets/Osteomalacia | Phase 1 | 2014-07-01 |
| Completed | A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Dis Alzheimer's Disease | Phase 1 | 2014-07-01 |
| Completed | The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers. Parkinson's Disease | Phase 1 | 2014-06-01 |
| Completed | Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis Secondary Hyperparathyroidism | Phase 1 | 2014-05-01 |
| Completed | Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients Parkinson Disease | — | 2014-03-01 |
| Completed | A Phase 3 Clinical Study of KHK 4827 Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris | Phase 3 | 2014-02-01 |
| Completed | A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma Liver Cancer | Phase 3 | 2014-01-01 |
| Completed | Phase 2 Study of KHK4577 Atopic Dermatitis | Phase 2 | 2013-11-01 |
| Completed | A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Dis Idiopathic Parkinson's Disease | Phase 3 | 2013-10-01 |
| Completed | Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis Hyperparathyroidism | Phase 1 / Phase 2 | 2013-08-01 |
| Completed | A Phase 3 Clinical Study of KHK4827 Psoriasis | Phase 3 | 2013-03-01 |
| Completed | An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis Psoriasis | Phase 3 | 2013-02-01 |
| Completed | A Phase 2 Clinical Study of KHK4827 Moderate to Severe Plaque Psoriasis | Phase 2 | 2012-12-01 |
| Completed | Study of ARQ 197 in Hepatocellular Carcinoma (HCC) Advanced Hepatocellular Carcinoma | Phase 1 | 2012-07-01 |
| Completed | ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lu Non-small-cell Lung Cancer | Phase 2 | 2012-05-01 |
| Completed | Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL) Peripheral T-Cell Lymphoma | Phase 2 | 2012-04-01 |
| Terminated | A Phase 3 Clinical Study of KW-3357 in Patients With DIC Disseminated Intravascular Coagulation (DIC) | Phase 3 | 2012-02-01 |
| Terminated | A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Ty Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | 2012-02-01 |
| Completed | A Comparative Study of KHK6188 Postherpetic Neuralgia | Phase 2 | 2012-02-01 |
| Completed | An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia X-linked Hypophosphatemia | Phase 1 / Phase 2 | 2012-02-01 |
| Terminated | A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | 2012-02-01 |
| Terminated | Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors Solid Tumour | Phase 1 | 2012-01-01 |
| Completed | A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome MDS | Phase 2 | 2011-12-01 |
| Completed | A Clinical Study of KW-3357 in Patients With DIC Disseminated Intravascular Coagulation (DIC) | Phase 3 | 2011-12-01 |
| Completed | An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Parathyroid Carcinoma, Hypercalcemia, Primary Hyperparathyroidism | Phase 3 | 2011-11-01 |
| Completed | A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis Psoriasis | Phase 1 | 2011-11-01 |
| Completed | Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors Solid Tumour, Adenocarcinoma of the Colorectal, Adenocarcinoma of the Pancreas | Phase 1 | 2011-10-01 |
| Completed | A Phase IIa Study of KHK4563 Uncontrolled and Suspected Eosinophilic Asthma | Phase 2 | 2011-08-01 |
| Terminated | A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Non-small-cell Lung Cancer | Phase 3 | 2011-07-01 |
| Completed | An Open-label Study of KW-3357 Disseminated Intravascular Coagulation (DIC) | Phase 3 | 2011-06-01 |
| Completed | A Study of LY2523355 in Patients With Solid Cancer Solid Tumors | Phase 1 | 2011-05-01 |
| Completed | A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia X-linked Hypophosphatemia | Phase 1 / Phase 2 | 2011-04-01 |
| Completed | A Comparative Study of KW-2246 Cancer Related Pain (Breakthrough Pain) | Phase 3 | 2011-03-01 |
| Terminated | Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 1 | 2011-01-01 |
| Completed | A Study of ARQ 197 in Combination With Erlotinib Advanced/Recurrent Non-small-cell Lung Cancer | Phase 1 | 2010-12-01 |
| Terminated | Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer Breast Cancer | Phase 1 | 2010-12-01 |
| Completed | Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma Peripheral T/NK-cell Lymphoma | Phase 2 | 2010-09-01 |
| Completed | Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma | Phase 2 | 2010-08-01 |
| Completed | A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes Diabetes, Type 2 | Phase 3 | 2010-07-01 |
| Completed | A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus Diabetes | Phase 3 | 2010-07-01 |
| Completed | Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 Adult T-cell Leukemia-Lymphoma | Phase 2 | 2010-07-01 |
| Completed | Study of ARQ 197 Monotherapy Gastric Cancer | Phase 2 | 2010-06-01 |
| Completed | Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects Healthy | Phase 1 | 2010-03-01 |
| Completed | A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2010-03-01 |
| Completed | A Study of ARQ 197 in Combination With Erlotinib Non-small-cell Lung Cancer | Phase 1 | 2010-02-01 |
| Completed | Extended Long-Term Safety Study of KW-6500 Parkinson's Disease | Phase 3 | 2010-01-01 |
| Completed | Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 Parkinson's Disease | Phase 3 | 2010-01-01 |
| Completed | A Study of OPC-262 in Patients With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2009-11-01 |
| Completed | Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients Parkinson's Disease | Phase 3 | 2009-10-01 |
| Completed | A Study of OPC-262 in Patients With Type 2 Diabetes Diabetes Type 2 | Phase 2 / Phase 3 | 2009-09-01 |
| Completed | Study of KRN951 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2009-08-01 |
| Completed | Along-term Study of OPC-262 in Patients With Type 2 Diabetes Diabetes, Type 2 | Phase 3 | 2009-08-01 |
| Completed | Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Parkinson's Disease | Phase 3 | 2009-07-01 |
| Completed | Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease Parkinson's Disease | Phase 3 | 2009-07-01 |
| Completed | Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor Solid Tumor | Phase 1 | 2009-06-01 |
| Completed | Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma Adult T-cell Leukemia-lymphoma | Phase 2 | 2009-06-01 |
| Completed | Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS) Healthy | Phase 1 | 2009-05-01 |
| Completed | Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma Peripheral T-Cell Lymphoma | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron Pharmacokinetics | Phase 1 | 2009-04-01 |
| Completed | PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron Healthy | Phase 1 | 2009-04-01 |
| Completed | A Study of KW-3357 in Congenital Antithrombin Deficiency Congenital Antithrombin Deficiency | Phase 1 | 2009-04-01 |
| Terminated | Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 2009-03-01 |
| Completed | A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes Diabetes, Type 2 | Phase 2 | 2009-01-01 |
| Terminated | Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) Acute Myelogenous Leukemia (AML) | Phase 1 | 2009-01-01 |
| Completed | A Study of KRN23 in X-linked Hypophosphatemia X-linked Hypophosphatemia | Phase 1 | 2008-12-01 |
| Terminated | Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma Multiple Myeloma | Phase 1 | 2008-10-01 |
| Completed | A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients Pain, Cancer | Phase 3 | 2008-03-01 |
| Completed | A Phase III Clinical Study of KW-2246 Pain, Cancer | Phase 3 | 2008-03-01 |
| Completed | A Phase 1 Study of ARQ 197 in Patients With Solid Tumors Cancer | Phase 1 | 2008-01-01 |
| Completed | Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease End Stage Renal Disease, Hyperparathyroidism, Secondary | — | 2008-01-01 |
| Completed | Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Parkinson's Disease | Phase 2 | 2007-11-01 |
| Completed | A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia Multiple Myeloma, Chronic Lymphocytic Leukaemia, B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2007-04-01 |
| Completed | A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levod Parkinson's Disease | Phase 2 | 2007-03-01 |
| Completed | Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL Adult T-Cell Leukemia and Lymphoma (ATL), Adult Peripheral T-Cell Lymphoma (PTCL) | Phase 1 | 2007-02-01 |
| Completed | Open Label Extension Study of AMG 531 in Japanese Subjects With ITP Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Phase 2 / Phase 3 | 2006-11-01 |
| Completed | A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor Anemia | Phase 2 | 2006-07-01 |
| Completed | Clinical Study of KW-2246 in Patients With Cancer Pain Pain, Cancer | Phase 2 | 2006-07-01 |
| Completed | Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients Neutropenia | Phase 2 | 2006-03-01 |
| Completed | A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients Anemia | Phase 3 | 2006-03-01 |
| Completed | Safety Study of AMG 531 in Japanese Subjects With ITP Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Phase 2 | 2006-02-01 |
| Completed | To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting Chemotherapy-induced Nausea and Vomiting | Phase 3 | 2006-01-01 |
| Completed | Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients. Pain, Cancer | Phase 3 | 2005-12-01 |
| Completed | Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients Pain, Cancer | Phase 3 | 2005-12-01 |
| Completed | A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease Parkinson's Disease | Phase 2 | 2005-11-01 |
| Completed | A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Parkinson's Disease | Phase 2 | 2005-04-01 |
| Completed | A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease Parkinson's Disease | Phase 3 | 2004-11-01 |
| Available | Expanded Access to Burosumab X-linked Hypophosphatemia, Tumor-Induced Osteomalacia | — | — |